Michael is a Partner at Sands Capital, where he has been since 2011. He specializes in investing in life sciences and therapeutics businesses across both private and public markets. A CFA charterholder, he earned his Bachelor of Science in Commerce from the University of Virginia and serves on multiple corporate boards.
There is no publicly available information about Michaels personal life or hobbies beyond his professional and educational background. His interests are closely tied to his work in the life sciences sector and his alma mater, the University of Virginia.
He serves on the Board of Directors for multiple biopharmaceutical companies, including Inspirna, Prilenia Therapeutics, and Blue Earth Therapeutics.
Michael Ginder, CFA
Partner at Sands Capital
Arlington, Virginia, United States
Overview
Topics They Care About
Life Sciences Investing
His entire career at Sands Capital since 2011 has been dedicated to investing in life sciences businesses across public and private markets.
Therapeutics Businesses
He has a primary focus on investing in therapeutics and serves on the boards of several therapeutics and biopharmaceutical companies.
Corporate Governance
He holds board member or board observer roles at companies like Inspirna, Blue Earth Therapeutics, Prilenia Therapeutics, and Avenzo Therapeutics, indicating deep involvement in corporate oversight.
Media Appearances
Michael has no verified media appearances
Work History
12-2022
Partner at Sands Capital
12-2016 - 1-2023
Research Analyst at Sands Capital
1-2014 - 12-2016
Sr. Research Associate at Sands Capital
6-2010 - 7-2010
Equity Research Intern at Morgan Joseph TriArtisan LLC
Education
2008 - 2011
Bachelor of Commerce (B.Com.) from University of Virginia
2007 - 2008
Education details unavailable from University of Notre Dame
More Information
Social Presence :
Prographics :
Exp : 12
Location : Arlington, Virginia, United States
Job Level : N/A
Designation : Partner at Sands Capital
